Tevozani Intermediate
have 1 Relevant products
Tevozani Is An Oral Tyrosine Kinase Inhibitor Of The Vascular Endothelial Growth Factor Receptor. It Has Completed A Three-Stage Investigation Of The Treatment Of First-Line (Infantile) Renal Cell Carcinoma Patients. The Results Of The First-Line Study We
